SPI Infoamtion

Table of Contents

Executive summary

The Business Intelligence market in the pharmaceutical sector
Key processes in the pharmaceutical sector
The uptake of Business Intelligence in the pharmaceutical sector
The demand side of Business Intelligence in the pharmaceutical sector
The Business Intelligence vendor landscape
The future of the Business Intelligence market in the pharmaceutical
sector

Chapter 1 Introduction

Introduction
Who is this report for?
Research methodology

Chapter 2 The Business Intelligence market in the pharmaceutical sector

Summary
Introduction
Importance of BI in the pharmaceutical industry
BI market in the pharmaceutical industry: size and growth
Drivers for BI adoption in the pharmaceutical industry

Enabling strategic decision making

Enabling identification of latest sales forecasts and trends

Increased outsourcing

Attaining cost efficiency

Challenges for implementing BI in the pharmaceutical industry
Current BI trends in the pharmaceutical industry

BI moving beyond operational excellence to technical areas

Customized service offering by BI vendors

Chapter 3 Key processes in the pharmaceutical sector

Summary
Introduction
Pharmaceutical processes

Drug discovery

Drug development

Manufacturing and supply chain

Sales and marketing

Chapter 4 The uptake of Business Intelligence in the pharmaceutical sector

Summary
Introduction
Business Intelligence uptake

Current BI usage

Uptake by organization size

Uptake by geographies

Short-term BI drivers among current users

Longer-term BI drivers among current users

BI usage forecast

BI usage forecast by components

BI usage forecast by enterprise functions

Planned increases in spending on Business Intelligence

Plans to increase usage: case for persuasion

Chapter 5 The demand side of Business Intelligence in the pharmaceutical sector

Summary
Introduction
Organizational priorities

Cost reduction: which areas to target?

Reducing SG&A costs

Cost reduction priorities

Business Intelligence users - case studies

GlaxoSmithKline - management of the clinical trial process and enhancement of drug development

Wyeth Pharma - managing sales effectiveness

Chapter 6 The Business Intelligence vendor

landscape
Summary
Introduction
The mega vendors

IBM Business Intelligence: Cognos, SPSS, ILOG, and IBM BAO

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

Microsoft Business Intelligence

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

Oracle

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

SAP BusinessObjects

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

Niche vendors

Actuate

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

Information Builders

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

MicroStrategy

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

QlikTech

Company overview

Key offerings and verticals

Pharmaceutical solution and major customers

Competitors

Growth strategies

SAS

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

TIBCO Spotfire

Company overview

Key offerings and verticals

Pharmaceutical solutions and major customers

Competitors

Growth strategies

Chapter 7 The future of the Business Intelligence market in the pharmaceutical sector

Summary
Introduction
Transition of the pharmaceutical sales and marketing model through
predictive analytics

Major vendors

Shifting to in-memory analytics helps rapid information delivery to the
sales force

Major vendors

Leveraging SaaS for data analytics

Major vendors

Open source paving its way into SMBs

Major vendors

Appendix

Glossary
Index

List of Figures
Figure 2.1: BI spending by big pharma in the US and Europe ($m), 2006-2012
Figure 2.2: Drivers and challenges for BI implementation in the pharmaceutical industry
Figure 2.3: Current BI trends in the pharmaceutical industry
Figure 3.4: Pharma-specific typical Business Intelligence solutions
Figure 4.5: BI usage by organizations (% respondents, 2010)
Figure 4.6: Current BI users by areas of operation (% respondents using BI, 2010)
Figure 4.7: BI users by organization size (% respondents, 2010)
Figure 4.8: BI users by geography (% respondents, 2010)
Figure 4.9: Short-term factors most likely to drive BI uptake among current users
Figure 4.10: Longer-term factors likely to drive BI uptake among current users (% respondents)
Figure 4.11: Forecast of BI usage by components (% respondents)
Figure 4.12: Forecast of BI usage by enterprise functions (% respondents)
Figure 4.13: Current user plans to change spending on BI in 2010-2011
Figure 4.14: Case for persuasion: current BI user indecisiveness by enterprise functions
Figure 5.15: Organizational priorities
Figure 5.16: Is reduction of SG&A costs a high priority in 2010?
Figure 5.17: Cost reduction priorities by enterprise function
Figure 6.18: Business Intelligence vendor landscape
Figure 6.19: Summary of the mega vendors
Figure 7.20: Spectrum of Business Intelligence technologies

List of Tables
Table 3.1: Drug discovery KPIs and BI solutions
Table 3.2: Drug development KPIs and BI solutions
Table 3.3: Manufacturing and supply chain KPIs and BI solutions
Table 3.4: Sales and marketing KPIs and BI solutions
Table 6.5: IBM Cognos Business Intelligence offerings
Table 6.6: IBM Cognos pharmaceutical solutions
Table 6.7: IBM major M&A deals, 2008-2010*
Table 6.8: Microsoft Business Intelligence offerings
Table 6.9: Microsoft Business Intelligence pharmaceutical solutions
Table 6.10: Microsoft Business Intelligence major M&A deals, 2008-2010*
Table 6.11: Oracle Business Intelligence offerings
Table 6.12: Oracle pharmaceutical solutions
Table 6.13: Oracle major M&A deals, 2008-10*
Table 6.14: SAP BusinessObjects Business Intelligence offerings
Table 6.15: SAP BusinessObjects pharmaceutical solutions
Table 6.16: SAP BusinessObjects major M&A deals, 2008-2010*
Table 6.17: Actuate Business Intelligence offerings
Table 6.18: Actuate pharmaceutical solutions
Table 6.19: Actuate major M&A deal, 2008-2010*
Table 6.20: Information Builders' Business Intelligence offerings
Table 6.21: Information Builders' pharmaceutical solutions
Table 6.22: MicroStrategy Business Intelligence offerings
Table 6.23: MicroStrategy pharmaceutical solutions
Table 6.24: QlikTech pharmaceutical solutions
Table 6.25: SAS Business Intelligence offerings
Table 6.26: SAS pharmaceutical solutions
Table 6.27: SAS major M&A deals, 2008-2010*
Table 6.28: TIBCO Spotfire Business Intelligence offerings
Table 6.29: TIBCO Spotfire pharmaceutical solutions
Table 6.30: TIBCO Spotfire major M&A deal, 2008-2010*